GABPA and lung cancer: Many studies have shown that under the action of ROS, the abnormal expression of Nrf2 can induce lung cancer, promote the proliferation of cancer cells and secretion of drug-resistant proteins, and inhibit p53 and Bcl-2 mediated apoptosis [21–25].